Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Bcl-2 overexpression in PhIP-induced colon tumors: cloning of the rat Bcl-2 promoter and characterization of a pathway involving β-catenin, c-Myc and E2F1

Oncogene volume 26, pages 6194–6202 (2007)Cite this article

Abstract

β-Catenin/T-cell factor (Tcf) signaling is constitutively active in the majority of human colorectal cancers, and there are accompanying changes in Bcl-2 expression. Similarly, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP)-induced colon tumors in the rat have increased β-catenin and elevated Bcl-2. To examine the possible direct transcriptional regulation of rat Bcl-2 by β-catenin/Tcf, we cloned and characterized the corresponding promoter region and found 70.1% similarity with its human counterpart, BCL2. Bcl-2 promoter activity was increased in response to LiCl and exogenous β-catenin, including oncogenic mutants of β-catenin found in PhIP-induced colon tumors. Protein/DNA arrays identified E2F1, but not β-catenin/Tcf, as interacting most strongly with the rat Bcl-2 promoter. Exogenous E2F1 increased the promoter activity of rat Bcl-2, except in mutants lacking the E2F1 sites. As expected, β-catenin induced its downstream target c-Myc, as well as E2F1 and Bcl-2, and this was blocked by siRNA to c-Myc or E2F1. These findings suggest an indirect pathway for Bcl-2 over-expression in PhIP-induced colon tumors involving β-catenin, c-Myc and E2F1.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Aberle H, Bauer A, Stappert J, Kispert A, Kemler R . (1997). β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797–3804.

    Article  CAS  Google Scholar 

  • Al-Fageeh M, Li Q, Dashwood WM, Myzak MC, Dashwood RH . (2004). Phosphorylation and ubiquitination of oncogenic mutants of β-catenin containing substitutions at Asp32. Oncogene 23: 4839–4846.

    Article  CAS  Google Scholar 

  • Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM et al. (1995). Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55: 1811–1816.

    CAS  PubMed  Google Scholar 

  • Behrens J . (2005). The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem Soc Trans 33: 672–675.

    Article  CAS  Google Scholar 

  • Blum CA, Xu M, Orner GA, Fong AT, Bailey GS, Stoner GD et al. (2001). β-Catenin mutation in rat colon tumors initiated by 1,2-dimethylhydrazine and 2-amino-3-methylimidazo[4,5-f]quinoline, and the effect of post-initiation treatment with chlorophyllin and indole-3-carbinol. Carcinogenesis 22: 315–320.

    Article  CAS  Google Scholar 

  • Blum CA, Tanaka T, Zhong X, Li Q, Dashwood WM, Pereira C et al. (2003). Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational ‘hotspots’ and the relative expression of β-catenin and c-jun. Mol Carcinogen 36: 195–203.

    Article  CAS  Google Scholar 

  • Dashwood RH, Suzui M, Nakagama H, Sugimura T, Nagao M . (1998). High frequency of β-catenin (Ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res 58: 1127–1129.

    CAS  PubMed  Google Scholar 

  • Dashwood WM, Orner GA, Dashwood RH . (2002). Inhibition of β-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H2O2 at physiologically relevant EGCG concentrations. Biochem Biophys Res Commun 296: 584–588.

    Article  CAS  Google Scholar 

  • Dashwood WM, Carter O, Al-Fageeh M, Li Q, Dashwood RH . (2005). Lysosomal trafficking of β-catenin induced by the tea polyphenol epigallocatechin-3-gallate. Mutat Res 591: 161–172.

    Article  CAS  Google Scholar 

  • Fujiwara K, Ochiai M, Ohta T, Ohki M, Aburatani H, Nagao M et al. (2004). Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis 25: 1495–1505.

    Article  CAS  Google Scholar 

  • Gomez-Manzano C, Mitlianga P, Fueyo J, Lee HY, Hu M, Spurgers KB et al. (2001). Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2. Cancer Res 61: 6693–6697.

    CAS  PubMed  Google Scholar 

  • Grossmann M, O'Reilly LA, Gugasyan R, Strasser A, Adams JM, Gerondakis S . (2000). The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J 19: 6351–6360.

    Article  CAS  Google Scholar 

  • Harigai M, Miyashita T, Hanada M, Reed JC . (1996). A cis-acting element in the BCL-2 gene controls expression through translational mechanisms. Oncogene 12: 1369–1374.

    CAS  PubMed  Google Scholar 

  • Hayashi R, Luk H, Horio D, Dashwood RH . (1996). Inhibition of apoptosis in colon tumors induced in the rat by 2-amino-3-methylimidazo[4,5-f]quinoline. Cancer Res 56: 4307–4310.

    CAS  PubMed  Google Scholar 

  • He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512.

    Article  CAS  Google Scholar 

  • Huang X, Wu DY, Chen G, Manji H, Chen DF . (2003). Support of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2-dependent mechanism. Invest Ophthalmol Vis Sci 44: 347–354.

    Article  Google Scholar 

  • Li Q, Dashwood WM, Zhong X, Al-Fageeh M, Dashwood RH . (2004). Cloning of the rat β-catenin gene (Ctnnb1) promoter and its functional analysis compared with the Catnb and CTNNB1 promoters. Genomics 83: 231–242.

    Article  CAS  Google Scholar 

  • Li Q, Dashwood RH . (2004). Activator protein-2α associates with adenomatous polyposis coli/β-catenin and inhibits β-catenin/T-cell factor transcriptional activity in colorectal cancer cells. J Biol Chem 269: 45669–45675.

    Article  Google Scholar 

  • Manji HK, Moore GJ, Chen G . (2000). Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry 61: 82–96.

    CAS  PubMed  Google Scholar 

  • Mayo MW, Wang C, Drouin SS, Madrid LV, Marshall AF, Reed JC et al. (1999). WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J 18: 3990–4003.

    Article  CAS  Google Scholar 

  • Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E et al. (2001). E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15: 267–285.

    Article  CAS  Google Scholar 

  • Ochiai M, Ushigome M, Fujiwara K, Ubagai T, Kawamori T, Sugimura T et al. (2003). Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-3-methylimidazo[4,5-f]quinoline. Am J Pathol 163: 1607–1614.

    Article  CAS  Google Scholar 

  • O'Donnell K, Wentzel EA, Zeller KI, Dang CV, Mendell JT . (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839–843.

    Article  CAS  Google Scholar 

  • Park S, Gwak J, Cho M, Song T, Won J, Kim DE et al. (2006). Hexachlorophene inhibits Wnt/β-catenin pathway by promoting Siah-mediated β-catenin degradation. Mol Pharmacol 70: 960–966.

    Article  CAS  Google Scholar 

  • Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich KA, Boxer LM et al. (1999). Insulin-like growth factor-1 induces bcl-2 promoter through a transcription factor cAMP-response element-binding protein. J Biol Chem 274: 2829–2837.

    Article  CAS  Google Scholar 

  • Romero O, Martinez AC, Camonis J, Rebollo A . (1999). Aiolos transcription factor controls cell death in T cells by regulating Bcl-2 expression and its cellular localization. EMBO J 18: 3419–3430.

    Article  CAS  Google Scholar 

  • Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P et al. (1988). Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J 7: 123–131.

    Article  CAS  Google Scholar 

  • Salomoni P, Perrotti D, Martinez R, Franceschi C, Calabretta B . (1997). Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and c-MYB-dependent regulation of bcl-2 promoter activity. Proc Natl Acad Sci USA 94: 3296–3301.

    Article  CAS  Google Scholar 

  • Smith MD, Ensor EA, Coffin RS, Boxer LM, Latchman DS . (1998). Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor. J Biol Chem 273: 16715–16722.

    Article  CAS  Google Scholar 

  • Tamatani M, Che YH, Matsuzaki H, Ogawa S, Okado S, Miyake S et al. (1999). Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons. J Biol Chem 274: 8531–8538.

    Article  CAS  Google Scholar 

  • Wilson BE, Mochon E, Boxer LM . (1996). Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apopotosis. Mol Cell Biol 16: 5546–5556.

    Article  CAS  Google Scholar 

  • Zeng G, Gao L, Xia T, Tencomnao T, Yu RK . (2003). Characterization of the 5′-flanking fragment of the human GM3-synthase gene. Biochim Biophys Acta 1625: 30–35.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Minako Nagao and Hideaki Inamori are gratefully acknowledged for their help in the studies with PhIP-induced colon tumors, which were supported by a fellowship from the Foundation for Promotion of Cancer Research, Tokyo, Japan. We thank Mark van de Wetering and Hans Clevers of University Hospital Utrecht, The Netherlands, for the wild-type β-catenin construct. This work was supported by NIH grants CA65525, CA80176 and CA90890, and by NIEHS center grant P30 ES00210.

Author information

Authors and Affiliations

  1. Linus Pauling Institute, Oregon State University, Corvallis, OR, USA

    Q Li, W M Dashwood, X Zhong & R H Dashwood

  2. National Cancer Center Research Institute, Tokyo, Japan

    H Nakagama

Authors
  1. Q Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W M Dashwood
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. X Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Nakagama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R H Dashwood
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R H Dashwood.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Q., Dashwood, W., Zhong, X. et al. Bcl-2 overexpression in PhIP-induced colon tumors: cloning of the rat Bcl-2 promoter and characterization of a pathway involving β-catenin, c-Myc and E2F1. Oncogene 26, 6194–6202 (2007). https://doi.org/10.1038/sj.onc.1210438

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210438

Keywords

This article is cited by

Search

Advanced search

Quick links